How to access photodynamic therapy for bile duct carcinoma

Annals of Translational Medicine

Volumn 2, Issue 3, 2014, Pages

  Nanashima, Atsushi ^a   Isomoto, Hajime ^a   Abo, Takafumi ^a   Nonaka, Takashi ^a   Morisaki, Tomohito ^a   Arai, Junichi ^a   Takagi, Katsunori ^a   Ohnita, Ken ^a   Shoji, Hiroyuki ^a   Urabe, Shigetoshi ^a   Senoo, Takemasa ^a   Murakami, Goshi ^a   Nagayasu, Takeshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Access route; Bile duct carcinoma (BDC); Endoscopy; Photodynamic therapy (PDT); Transhepatic; Transjejunal; Transpapillary

Indexed keywords

EID: 85015477827     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.3978/j.issn.2305-5839.2014.03.04     Document Type: Article

References (29)

1. Tamada K, Sugano K. Diagnosis and non-surgical treatment of bile duct carcinoma: developments in the past decade. J Gastroenterol 2000;35:319-25.
2. Nakagohri T, Asano T, Kinoshita H, et al. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma. World J Surg 2003;27:289-93.
3. Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 2002;51:VI1-9.
4. Bowling TE, Galbraith SM, Hatfield AR, et al. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 1996;39:852-5.
5. Indar AA, Lobo DN, Gilliam AD, et al. Percutaneous biliary metal wall stenting in malignant obstructive jaundice. Eur J Gastroenterol Hepatol 2003;15:915-9.
6. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003;3:380-7.
7. Berr F, Wiedmann M, Tannapfel A, et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 2000;31:291-8.
8. Witzigmann H, Berr F, Ringel U, et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg 2006;244:230-9.
9. Nanashima A, Yamaguchi H, Shibasaki S, et al. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study. J Gastroenterol 2004;39:1095-101.
10. Nanashima A, Abo T, Nonaka T, et al. Photodynamic therapy using talaporfin sodium (Laserphyrin®) for bile duct carcinoma: a preliminary clinical trial. Anticancer Res 2012;32:4931-8.
11. Ortner ME, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003;125:1355-63.
12. Zoepf T, Jakobs R, Arnold JC, et al. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 2005;100:2426-30.
13. Rumalla A, Baron TH, Wang KK, et al. Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc 2001;53:500-4.
14. Japanese Society of Biliary Surgery (JSBS). Part II Extrahepatic bile duct. In: Nagakawa T. eds. Classification of Biliary tract Carcinoma. First English ed. Tokyo: Kanehara & Co., Ltd., 2001:12-32.
15. Pereira SP, Aithal GP, Ragunath K, et al. Safety and long term efficacy of porfimer sodium photodynamic therapy in locally advanced biliary tract carcinoma. Photodiagnosis Photodyn Ther 2012;9:287-92.
16. Kasuya K, Shimazu M, Suzuki M, et al. Novel photodynamic therapy against biliary tract carcinoma using mono-L:-aspartyl chlorine e6: basic evaluation for its feasibility and efficacy. J Hepatobiliary Pancreat Sci 2010;17:313-21.
17. Yoshida T, Tokashiki R, Ito H, et al. Therapeutic effects of a new photosensitizer for photodynamic therapy of early head and neck cancer in relation to tissue concentration. Auris Nasus Larynx 2008;35:545-51.
18. Matull WR, Dhar DK, Ayaru L, et al. R0 but not R1/R2 resection is associated with better survival than palliative photodynamic therapy in biliary tract cancer. Liver Int 2011;31:99-107.
19. Nanashima A, Tobinaga S, Abo T, et al. Experience of surgical resection for hilar cholangiocarcinomas at a Japanese single cancer institute. Hepatogastroenterology 2012;59:347-50.
20. Nanashima A, Sumida Y, Tobinaga S, et al. Characteristics of bile duct carcinoma with superficial extension in the epithelium. World J Surg 2009;33:1255-8.
21. Wiedmann M, Caca K, Berr F, et al. Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study. Cancer 2003;97:2783-90.
22. Allison RR, Zervos E, Sibata CH. Cholangiocarcinoma: an emerging indication for photodynamic therapy. Photodiagnosis Photodyn Ther 2009;6:84-92.
23. Choi HJ, Moon JH, Ko BM, et al. Clinical feasibility of direct peroral cholangioscopy-guided photodynamic therapy for inoperable cholangiocarcinoma performed by using an ultra-slim upper endoscope (with videos). Gastrointest Endosc 2011;73:808-13.
24. Saito H, Takada T, Miyazaki M, et al. Radiation therapy and photodynamic therapy for biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 2008;15:63-8.
25. Ferrario A, Kessel D, Gomer CJ. Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model. Cancer Res 1992;52:2890-3.
26. Roberts WG, Smith KM, McCullough JL, et al. Skin photosensitivity and photodestruction of several potential photodynamic sensitizers. Photochem Photobiol 1989;49:431-8.
27. Sugiyama H, Tsuyuguchi T, Sakai Y, et al. Potential role of peroral cholangioscopy for preoperative diagnosis of cholangiocarcinoma. Surg Laparosc Endosc Percutan Tech 2012;22:532-6.
28. Harewood GC, Baron TH, Rumalla A, et al. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma. J Gastroenterol Hepatol 2005;20:415-20.
29. Nonaka T, Nanashima A, Nonaka M, et al. Advantages of laserphyrin compared with photofrin in photodynamic therapy for bile duct carcinoma. J Hepatobiliary Pancreat Sci 2011;18:592-600.